1293992-56-9

Basic information

• Product Name: 7-(butylamino)-6,8-difluoro-4-oxo-1-(4-(trifluoromethyl)benzyl)-1,4-dihydroquinoline-3-carboxylic acid
• Synonyms: 7-(butylamino)-6,8-difluoro-4-oxo-1-(4-(trifluoromethyl)benzyl)-1,4-dihydroquinoline-3-carboxylic acid
• CAS NO: 1293992-56-9
• Molecular Weight: 454.396
• Mol File: 1293992-56-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 7-(butylamino)-6,8-difluoro-4-oxo-1-(4-(trifluoromethyl)benzyl)-1,4-dihydroquinoline-3-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 7-(butylamino)-6,8-difluoro-4-oxo-1-(4-(trifluoromethyl)benzyl)-1,4-dihydroquinoline-3-carboxylic acid(1293992-56-9)
• EPA Substance Registry System: 7-(butylamino)-6,8-difluoro-4-oxo-1-(4-(trifluoromethyl)benzyl)-1,4-dihydroquinoline-3-carboxylic acid(1293992-56-9)

Safety Data

• Hazardous Substances Data: 1293992-56-9(Hazardous Substances Data)

Upstream product

• 214602-42-3 ethyl-6,7,8-trifluoro-4-oxo-1-(4-(trifluoromethyl)benzyl)-1,4-dihydroquinoline-3-carboxylate 
• 100501-60-8 diethyl 2-((2,3,4-trifluorophenylamino)methylene)malonate 
• 79660-46-1 ethyl 6,7,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate 
• 3862-73-5 2,3,4-trifluoroaniline 
• 1293992-41-2 6,7,8-trifluoro-4-oxo-1-(4-(trifluoromethyl)benzyl)-1,4-dihydroquinoline-3-carboxylic acid 
• 109-73-9 N-butylamine 

Relevant articles and documents

Synthesis and antibacterial evaluation of novel 8-fluoro Norfloxacin derivatives as potential probes for methicillin and vancomycin-resistant Staphylococcus aureus

A series of novel 8-fluoro Norfloxacin derivatives and the hybrids of its piperazinyl derivatives incorporated with 1,3,5-triazine and pyrimidine were synthesized. All the above compounds were evaluated for their antibacterial activity against Klebsiella pneumoniae, methicillin-resistant Staphylococcus aureus and methicillin & vancomycin-resistant S. aureus. Among all, compounds having Morpholine, N-methyl/phenyl/benzyl/pyrimidinyl piperazines and n-butylamine substitution at C-7 position, have shown increased potency in comparison to norfloxacin and ciprofloxacin.